CHRISTINA WOODS: Open Payments
NPI 1780293027 · CORBIN, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$705 in 41 payments from 11 companies in 2025. Trend: 2023 $225 · 2024 $507 · 2025 $705
Food & beverage: $705
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 24 | $396 |
| ABBVIE INC. | 4 | $57 |
| Neurocrine BioSciences, Inc. | 3 | $57 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $33 |
| E.R. Squibb & Sons, L.L.C. | 2 | $32 |
| Biogen, Inc. | 1 | $29 |
| Janssen Pharmaceuticals, Inc | 1 | $24 |
| Teva Pharmaceuticals USA, Inc. | 1 | $22 |
| Collegium Pharmaceutical, Inc. | 1 | $20 |
| Otsuka America Pharmaceutical, Inc. | 1 | $19 |
Products named: ARISTADA, VRAYLAR, INGREZZA, CAPLYTA, COBENFY, ZURZUVAE, LYBALVI, INVEGA SUSTENNA.
Industry payments across KY — which companies pay providers there.
